anti-DC-ASGPR vaccine (Baylor Research Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-DC-ASGPR vaccine (Baylor Research Institute)

Drug Alias Nameanti-dendritic cell asialoglycoprotein receptor DC-ASGPR antibodies + antigens (Baylor Research Institute)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines

Mechanisms of ActionAsialoglycoprotein receptor antagonists

TargetsAsialoglycoprotein receptor

Therapy Area/IndicationsGraft vs Host DiseaseMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor Research Institute Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBaylor Research Institute Llc

Active IndicationsN/A

Inactive IndicationsGraft vs Host DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A